B. Riley Weighs in on Verastem’s Q2 Earnings (NASDAQ:VSTM)
Verastem, Inc. (NASDAQ:VSTM – Free Report) – Stock analysts at B. Riley reduced their Q2 2025 earnings per share (EPS) estimates for shares of Verastem in a research report issued on Monday, April 28th. B. Riley analyst K. Patel now forecasts that the biopharmaceutical company will post earnings of ($0.56) per share for the quarter, […]
Verastem, Inc. (NASDAQ:VSTM – Free Report) – Stock analysts at B. Riley reduced their Q2 2025 earnings per share (EPS) estimates for shares of Verastem in a research report issued on Monday, April 28th. B. Riley analyst K. Patel now forecasts that the biopharmaceutical company will post earnings of ($0.56) per share for the quarter, […]
